Immunizations used to treat COVID-19, respiratory syncytial virus (RSV) and influenza safely reduce the risk of adverse outcomes among people of all ages, according to a systematic analysis of 511 ...

The investigators used a test-negative case-control design to estimate the vaccine effectiveness (VE) of the RSVpreF (Abrysvo ...

Environmental exposure to trichloroethylene may increase the risk for developing Parkinson’s disease, particularly in heavily ...

Individuals diagnosed with chronic spontaneous urticaria (CSU) are at a moderately increased risk of multiple cardiovascular ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a Phase 4 study titled ‘A Phase 4 Study Using a ...

Familial clustering was identified in primary hyperparathyroidism, as first-degree relatives were at higher risk than control patients.

A single RSV vaccine dose is proving to be a powerful shield for older adults, significantly reducing hospitalizations and severe illness over two consecutive RSV seasons. While protection is ...

The shingles vaccine is intended to prevent shingles, but a new study suggests that it could have major secondary benefits.

Objective To determine if two-dimensional (2D) video-based angular measurements obtained during dynamic tasks predict secondary anterior cruciate ligament (ACL) injury in female athletes post-ACL ...